Literature DB >> 12091244

Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.

Bernard Thébaud1, Thierry Petit, Pascal De Lagausie, Josette Dall'Ava-Santucci, Jean-Christophe Mercier, A Tuan Dinh-Xuan.   

Abstract

Nitric oxide (NO) plays a major role in the modulation of perinatal pulmonary vascular tone. Congenital diaphragmatic hernia (CDH), a major cause of severe persistent pulmonary hypertension of the newborn (PPHN), is often refractory to inhaled NO. Alterations in NO/cyclic guanosine 3',5' monophosphate (cGMP)-mediated pulmonary vasodilatation may contribute to PPHN in CDH. We assessed NO/cGMP-mediated pulmonary vasorelaxation in vitro in 140-d gestational lamb fetuses with surgically created left CDH (term = 147 d) to age-matched controls. Relaxation of fourth generation intralobar pulmonary artery rings in response to the endothelium-dependent vasodilator, acetylcholine (ACh), and to the specific inhibitor of cGMP-phosphodiesterase (PDE), zaprinast, did not differ between the two groups. By contrast, relaxation in response to the calcium ionophore A23187 was impaired in CDH as compared with control animals. Relaxation in response to the NO donor sodium nitroprusside (SNP) (a direct activator of soluble guanylyl cyclase [sGC]) was also impaired in CDH animals as compared with controls. Repeating the challenge increased vasorelaxation in response to SNP in CDH as compared with control animals. Immunohistochemistry revealed the presence of endothelial NO-synthase in the endothelium of pulmonary arteries from both control and CDH animals. We conclude that endothelium-dependent vasodilatation in response to ACh and A23187 was differently affected in the fetal surgical CDH-lamb model. Furthermore, activity of sGC but not that of PDE was impaired in CDH animals. PPHN and decreased inhaled NO responsiveness in CDH may involve decreased sGC activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091244     DOI: 10.1165/ajrcmb.27.1.4712

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  5 in total

1.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

2.  Antenatal BAY 41-2272 reduces pulmonary hypertension in the rabbit model of congenital diaphragmatic hernia.

Authors:  Aline Vuckovic; Susanne Herber-Jonat; Andreas W Flemmer; Brigitte Strizek; Alexander C Engels; Jacques C Jani
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-12       Impact factor: 5.464

3.  Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia.

Authors:  Eveline H Shue; Samuel C Schecter; Wenhui Gong; Mozziyar Etemadi; Michael Johengen; Corey Iqbal; S Christopher Derderian; Peter Oishi; Jeffrey R Fineman; Doug Miniati
Journal:  J Pediatr Surg       Date:  2013-10-05       Impact factor: 2.545

Review 4.  Inhaled NO in the experimental setting.

Authors:  Nicolas F M Porta; Robin H Steinhorn
Journal:  Early Hum Dev       Date:  2008-10-22       Impact factor: 2.079

5.  Altered pulmonary artery endothelial-smooth muscle cell interactions in experimental congenital diaphragmatic hernia.

Authors:  Shannon N Acker; Gregory J Seedorf; Steven H Abman; Eva Nozik-Grayck; Katherine Kuhn; David A Partrick; Jason Gien
Journal:  Pediatr Res       Date:  2015-01-12       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.